SCHEMBL19998697

SCHEMBL19998697

c1ccc(N(c2ccccc2)c2ccc3c(c2)-c2cccc4cccc-3c24)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
MAPK1 P28482 4/20 0.54
HSD17B10 Q99714 4/20 0.54
L3MBTL1 Q9Y468 4/20 0.54
TSHR P16473 3/20 0.54
ATM Q13315 3/20 0.54
CASP1 P29466 3/20 0.53
CASP7 P55210 2/20 0.53
HPGD P15428 2/20 0.53
HIF1A Q16665 2/20 0.53
TP53 P04637 1/20 0.53
CYP3A4 P08684 2/20 0.44
PABPC1 P11940 1/20 0.44
DNMT1 P26358 1/20 0.44
KDM4E B2RXH2 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29673992 0.95 ALDH1A1 (0.48) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL76169 0.95 ALDH1A1 (0.48) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL6844449 0.94 ALDH1A1 (0.47) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL23546666 0.92 ALDH1A1 (0.48) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL23546646 0.92 ALDH1A1 (0.48) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL4762034 0.90 ALDH1A1 (0.47) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL15306129 0.89 ALDH1A1 (0.43) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL24079012 0.88 ALDH1A1 (0.45) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL5162895 0.88 ALDH1A1 (0.42) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR
SCHEMBL17132454 0.87 MAPK1 (0.41) ALDH1A1MAPK1HSD17B10L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 US disclosed
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC18A1, SLC1A2, SLC43A1 ALDH1A1 764/4885MAPK1 1829/4885HSD17B10 2694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.